News

A Tribute To A Legend In The Global Bone Arena

APCO mourns the passing of, and pays tribute to Professor Harry K Genant, a friend, respected colleague, and a true legend in the bone field. Dr Genant was Professor Emeritus, University of California San Francisco (UCSF), and Senior Consultant, and Chairman Emeritus of Bioclinica-Synarc, Inc. – a global contract research organization he co-founded in 1998, …

A Tribute To A Legend In The Global Bone Arena Read More »

Hip fractures – Avoiding the black hole of missed management opportunities

Dr Nigel Gilchrist, Canterbury District Health Board, Christchurch, New Zealand and APCO Executive Committee Member Hip fractures in old adults are common, affecting up to 18 per cent of women and 6 per cent of men in their lifetime, and are associated with significant mortality and burden of disease. In the setting of prompt surgery and …

Hip fractures – Avoiding the black hole of missed management opportunities Read More »

Cost-effective fracture-probability based intervention thresholds for osteoporosis – one size does not fit all countries

The number of individuals at risk for fragility fractures worldwide is predicted to increase two-fold from the 158 million it was in 2010, to 319 million in 2040. This grave projection is going to be felt most keenly in Asia; home to 4.5 billion people and to several rapidly aging societies. The financial costs associated …

Cost-effective fracture-probability based intervention thresholds for osteoporosis – one size does not fit all countries Read More »

Modern day Alchemy? Bisphosphonates – the Elixir of Life?

Through millennia, alchemists and dreamers have striven to formulate the elixir of immortality and have failed – dramatically, ignominiously, and sometimes tragically. It is interesting to speculate whether bisphosphonates – agents that have been in clinical use for more than half a century, and in use for a quarter of that to inhibit bone resorption, …

Modern day Alchemy? Bisphosphonates – the Elixir of Life? Read More »

Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam

A Developing economy with a per-capita GDP of around $2,600 (2018 figures), Việt Nam is the 15th most populous country in the world. It has a population of 97 million. The country’s population is greying fast. Although at present the proportion of the country’s population aged 60 years and older is 12%,  this is expected …

Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam Read More »

Speaking up for the ‘silent disease’ in the Asia Pacific

APCO round-up of World Osteoporosis Day 2020 activities   Last Tuesday, October 20, 2020, members of the Asia Pacific Consortium on Osteoporosis (APCO) celebrated with gusto, World Osteoporosis Day (WOD) – an annual International Osteoporosis Foundation (IOF) campaign designed to promote public awareness of osteoporosis, and to support local bone health-related activities in its more …

Speaking up for the ‘silent disease’ in the Asia Pacific Read More »

Osteoporosis and fragility fractures – a family affair

Celebrating World Osteoporosis Day 2020   The Asia Pacific Consortium on Osteoporosis (APCO) is delighted to be celebrating World Osteoporosis Day (WOD) today (Tuesday, October 20). WOD is an annual, campaign that was conceptualised in 1997 by the National Osteoporosis Society of the UK and later adopted by the International Osteoporosis Foundation (IOF). It is …

Osteoporosis and fragility fractures – a family affair Read More »

Goal Directed Therapy in osteoporosis: a target in sight or still a pipe-dream?

“Goal Directed Therapy” (GDT) is a patient care approach designed to improve patient outcomes, and is well established following its initial introduction in critical care. In areas such as rheumatoid arthritis and diabetes, GDT is commonplace, with evidence to support its benefit. The question of how GDT can be applied in the management of the …

Goal Directed Therapy in osteoporosis: a target in sight or still a pipe-dream? Read More »

Breakable bones and genes – How can doctors utilise genes for fracture risk assessment?

More than 300 genetic variants have been discovered to be associated with osteoporosis or fracture. The magnitude of effect of these variants on fracture risk is very modest. One may ask: how can doctors utilise genes for fracture risk assessment? Consider the following case: a 70 year old woman whose femoral neck BMD is 0.72 …

Breakable bones and genes – How can doctors utilise genes for fracture risk assessment? Read More »

Innovative approaches to driving public awareness of bone health

In December 2012, Osteoporosis New Zealand (ONZ) published BoneCare 2020 which called for implementation of a systematic approach to hip fracture care and prevention for New Zealand. This included establishing a national hip fracture registry to benchmark care against quality standards and nationwide implementation of Fracture Liaison Services (FLS), to ensure all people who sustain …

Innovative approaches to driving public awareness of bone health Read More »

Scroll to Top